Test shows efficacy in detecting neuropathy in diabetes

05/6/2013 | Healio

A study presented at the American Association of Clinical Endocrinologists annual meeting found diabetes patients with neuropathy showed worse electrochemical skin conductance, as measured by the FDA-approved Sudoscan test, than those who did not have neuropathy. Researchers said the test may be useful for early diagnosis of diabetic neuropathy and for evaluation of responses to therapeutic interventions.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC